Target Of Rapamycin
International science club in France

Tor de France meeting 5th edition

4-5 October 2027, Nice

TOR de France Association

TOR de France (TdF) is a scientific association founded in 2024. Its mission is to advance research and promote the dissemination of knowledge on the TOR (Target of Rapamycin) signalling pathway, as well as the consequences of its alteration in disease.

To achieve its goals, the association :

Through these activities, TdF contributes to building a dynamic and collaborative research environment at both national and international levels.

Learn more about the TdF association (link to about at the end of community).

h

Pub Highlights

Edi_TOR_s pick

Cancer

Rethinking kidney cancer through the lens of microphthalmia (MiT)/transcription factor E (TFE) Biology

Cell biology

mTOR and Extracellular Vesicles: Linking Chemical Stress to Ecological Communication

Plant biology

From light perception to energy signaling: integrating carbon dynamics with the Tre6P-SnRK1-TOR growth-stress axis

Neuroscience

Translational control of microglial metabolism, inflammatory responses, and survival by the eIF4E-binding proteins

Gastroenterology

Loss of intestinal Akt elicits rapid mortality via intestinal damage which is rescued by mTORC1 activation

Cancer

CASTOR1 functional inactivation drives KRAS-mutant NSCLC and therapy resistance by a noncanonical mechanism of tumor suppression

Pharmacology

Gedatolisib: First Approval

Cell biology

cAMP signaling promotes acute lysosome biogenesis through TFEB nuclear import-export dynamics

Cell biology

Chromatin stability safeguards mitochondrial homeostasis and restrains TORC1 signaling

Aging

Caloric restriction mimetics rewire the AMPK-mTOR-ULK1 signaling nexus to restore autophagic proteostasis in the aging brain

 

Upcoming events

Autophagy in Health and Disease: From Mechanisms to Therapeutics


Feb 08–11, 2027 | Fairmont Banff Springs, Banff, AB, Canada
Focus: Autophagy, lysosomal signalling, mTORC1

GRC: Lysosomal Diseases


May 16-21, 2027 | Les Diablerets, Switzerland
Focus: Lysosomal biology, Rag GTPases, mTORC1–TFEB signalling

CSHL: Mechanisms of Metabolic Signaling


May 17-21, 2027 | Cold Spring Harbor, New York, USA

Focus: Nutrient sensing, metabolic regulation, TORC1 signalling

MENTOR school mTOR parthophysiology


June 7-11, 2027 | Madrid, Spain

Focus: parthophysiology

U

News & Views


TOR de France board

Svetlana Dokudovskaya

IGR, Villejuif, France

Mario Pende

Necker Institute, Paris, France

Stéphanie Baulac

ICM, Paris, France

CommunicaTORs

Alisa Kirkin

University of Fribourg, Switzerland

Lucas Van Endert

ICM, Paris, France

OrganisaTOR / AdministraTOR

Adrien Schramm

Stéphane Bou